A pilot study of scalp skin temperature during scalp cooling in patients treated with chemotherapy

Completed

• Conditions: alopecia; hair loss; 10006291

• Registration Number: NL-OMON35108
• Lead Sponsor: Medisch Centrum Alkmaar

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 12

Inclusion Criteria

Intravenous administered FEC-regimen with an epirubicine dose of 90 mg/m2 or more at 3-weekly intervals, age 18 years or more, written informed consent

Exclusion Criteria

Boldness before the start of the study, hematological malignancies with generalized haematogenic metastases and clinical signs of scalp metastases

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Little is known about the influence of temperature on the outcome of scalp<br /><br>cooling. This pilot study will check the feasibility of the main study, after<br /><br>which specific parameters/outcome will be defined. Hair loss will be measured<br /><br>using the World Health Organisation (WHO) grading system for alopecia and<br /><br>asking the patient whether or not a wig or shawl is required.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>n.v.t.</p><br>